Aberrant angiogenesis and defective epithelial repair are key features of Idiopathic pulmonary fibrosis (IPF). Endostatin is an anti-angiogenic peptide with known effects on endothelial cells. This study aimed to establish the levels of endostatin in the bronchoalveolar lavage fluid (BALF) in IPF and to investigate its actions on distal lung epithelial cells (DLEC) and primary type II cells. Apoptosis and cell viability were assessed.
Introduction
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease of unknown aetiology (1) . Current theories speculate that IPF results from abnormal wound healing in response to multiple, microscopic sites of alveolar epithelial cell (AEC) injury, activation and apoptosis (2) . AEC apoptosis has been implicated in the initiation of fibrotic foci (3;4) and an increased rate of apoptosis could contribute to the loss of balance in cell turnover and abnormal re-epithelialization. Caspase inhibition blocks AEC apoptosis and reduces the accumulation of collagen matrix in animal models (5) .
Collagens are a family of extra-cellular matrix (ECM) proteins that play a dominant role in maintaining the tissue structural integrity. Excessive collagen deposition leads to fibrosis disrupting the normal functioning of surrounding tissues (6) . Collagen XVIII is a major proteoglycan found in alveolar capillary and epithelial basement membranes.
Proteolytic enzymes cleave peptide bonds within the protease sensitive hinge region of collagen XVIII to release anti-angiogenic endostatin fragments varying in size between 20 and 30 kDa (7) . Endostatin has been implicated in the microvascular damage found in pre-eclampsia and can be used to suppress tumour neovascularization/angiogenesis in mice (8) . Endostatin levels have previously been found to be elevated in the serum of patients with IPF (9) .
Endostatin inhibits proliferation and migration of endothelial cells by interruption of focal adhesions and actin stress fibres, essential to cell motility (10). Endostatin induces endothelial cell apoptosis (11) and has been shown to associate with α 5β1 integrin, essential for endothelial cell proliferation and apoptosis (12) , and VEGFR-2 (13) . Given the importance of the epithelium in IPF and the fact AEC express both α 5β1 integrin (14) and VEGFR-2(15), we hypothesized that endostatin may have a role in inhibiting AEC repair in patients with IPF.
Matrix metalloproteinases (MMP) are essential for ECM remodeling, wound repair, and angiogenesis and have been implicated in the pathogenesis of IPF. MMP-3 (stromelysin-1) has a wide range of actions influencing fibrinolysis, angiogenesis (16) and is able to cleave endostatin from Collagen XVIII (17) . Establishing MMP-3 levels would give an indication of the potential for local proteolytic cleavage of endostatin.
The relationship between endostatin and cytokine networks is undetermined, but it is known endostatin is able to alter expression of a wide range of genes (18) . CXC cytokines that contain the terminal glu-leu-arg (ELR+ve) motif are potent induces of angiogenesis. Cytokines that don't present this motif (ELR-ve) which are mainly IFN inducible are in contrast anti-angiogenic. An imbalance in pro and anti-angiogenic CXC cytokines, has been described in IPF (19) .
The study aims were to determine bronchoalveolar lavage fluid (BALF) and plasma endostatin levels in IPF and WG and then relate endostatin to lung function and alveolar cytokine levels. In vitro experiments were designed to establish whether physiological levels of endostatin can influence human primary distal lung epithelial cell actions and propose a potential mechanism of action. 
Methods

Subjects
Measurements
Patients underwent bronchoscopy and bronchoalveolar lavage (BAL) as described previously (20) . Endostatin was measured in BALF and plasma by ELISA kit (R&D) according to manufacturer's instruction. BALF cytokines (IL-8, ENA78, IL1RA, IL-6, MCP-1, IFNγ) and MMP-3 were measured by Luminex array (R&D systems).
Protein was measured using the Bio-Rad DC protein assay kit II. The protein permeability index (PPI) was calculated as the ratio of BALF to plasma protein as described previously (21) .
Pulmonary function testing
Forced vital capacity (FVC) was measured using the Jaeger Compact system (Viasys Healthcare). Total lung diffusing capacity for carbon monoxide (TLCO) was measured by single-breath technique (Jaeger Compact system). Results were expressed as the percent of predicted values.
Cell culture
Primary human distal lung epithelial cells (DLEC) (Cambrex) were cultured in complete growth media (SAGM, Cambrex), according to manufacturer's protocol. Cells were obtained from 3 separate donors and experiments were performed before passage 3.
Confluent DLEC monolayers were wounded with a 2mm mechanical wound as described previously (22) . The wounds were photographed under microscope at 0 and 18 hours and analysed with Scion image software.
A dose response of 0-1000ng/ml of endostatin (Molecular Probes) on DLEC wound repair was assessed. Experiments were then repeated by incubating endostatin alone or pre-incubating with anti-FasL antibody (1ng/ml)(R&D) or the caspase inhibitor Z-
DEVD-FMK (20µM)(R&D).
Actions of endostatin on DLEC apoptosis and cell viability DLEC apoptosis was assessed using annexin/ propidium iodide fluorochromes 
Statistics
Normally distributed data, assessed by Kolmogorov-Smirnoff test is presented as mean ± standard error (SE Cell titre colorimetric assay showed reduced cell viability in endostatin treated DLEC cells and that this effect was enhanced at a higher dose (p<0.001) (figure 3b).
Effect of endostatin upon Primary human ATII cell wound repair and proliferation.
Endostatin caused a dose dependent reduction in wound repair after 48 hours (fig 4a) . Endostatin levels in the IPF lung may be elevated because of increased local cleavage of alveolar collagen XVIII. Gene expression array data suggests an increase in type XVIII collagen mRNA in whole lung extracts from IPF patients (25) and in an animal model of FasL induced lung injury there is upregulation of type XVIII collagen mRNA (26) .
Although our correlations between MMP-3 and endostatin do not prove a mechanistic link, taken together with our findings of increased BALF MMP-3 in IPF, this data suggests that local intra-alveolar degradation of type XVIII collagen may be important in endostatin generation. The proteolytic cleavage of collagen XVIII may only partially govern endostatin levels as has been shown that endothelial endostatin release may be induced by general cell stress and can be modulated by the nitric oxide/cGMP pathway (27) . A wide range of inflammatory cytokines were measured in this study and found to correlate with endostatin suggesting endostatin generation may be up regulated by an alveolar inflammatory milieu. Alternatively the observed relationship between BALF endostatin and protein permeability, and the plasma: BALF endostatin gradient suggests that alveolar levels of endostatin may be raised due to leakage from the microvasculature into the alveolus at sites of increased alveolar barrier permeability.
Given the anti-endothelial cell actions of endostatin, endostatin may play a pathophysiological role in this abnormal permeability.
Prior to this study the main focus of research into the biological effects of endostatin was upon endothelial cells in angiogenesis and cancer biology. The actions of endostatin on endothelial cells has variously been shown to reduce migration, spreading and induce apoptosis (28;29) . Not all studies have confirmed these effects and often these experiments have used supra-physiological doses. This study described the actions of It has been suggested that disordered epithelial remodeling promotes fibroproliferation in IPF. Endostatin can interact with both integrins and VEGFR-2 which are known to be present upon epithelial cells (12) . The known effects of endostatin upon WNT and cyclin D1 expression may be important in its epithelial effects since pulmonary epithelial cell turnover is also regulated by these signaling pathways (31) . . Further work to characterize the mechanism of endostatin action upon epithelial cells is required. Nevertheless our study suggests that there may be a direct link between collagen degradation and ongoing epithelial cell apoptosis induced by endostatin production in patients with IPF.
This study has several limitations. Firstly our patient population did not all have lung biopsies to prove UIP although they were well characterised according to international guidelines in a specialist clinic. Furthermore, the difference in age between the IPF patients and our healthy controls may be a confounding factor when comparing endostatin levels. To address this we examined the relationship between age and endostatin levels in IPF and normal controls and found no correlation. Finally we are unable to assess the relative importance of endostatin within BALF in an angiogenesis bioassay due to the current lack of an effective inhibitor of endostatin bioactivity.
In conclusion, this study has demonstrated elevated endostatin levels in IPF patients.
Endostatin levels correlated with the degree of lung function impairment and levels of inflammatory mediators that are associated with angiogenesis. Endostatin has been found to inhibit primary epithelial cell wound repair by mechanisms that involve both increased apoptosis rates or inhibition of proliferation. In conjunction with its antiangiogenic properties therefore, the presence of endostatin within the lung in IPF may result in defective alveolar epithelial repair. This study raises the possibility of an endostatin inhibitor as a therapeutic option in IPF. 
